Nebraska Right to Try Act Would Reject Some FDA Restrictions on Terminal Patients
LINCOLN, Neb. (Jan. 13, 2016) – A bill introduced in the Nebraska Senate would set the foundation to nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Introduced by Sen. Bob Hilkemann (R-Omaha), LB117 would give terminally ill patients access to medicines not yet given final approval…